Overview

Reverie Labs uses computational drug discovery to speed up cancer therapy development by partnering with pharmaceutical and biotech firms to identify and optimize drug candidates. Their approach blends machine learning, cheminformatics, physics, biology, and chemistry to build models and workflows that search chemical space and guide chemistry decisions. They differentiate themselves through an interdisciplinary team delivering practical, collaborative drug discovery programs, as shown by partnerships such as Roche/Genentech. The goal is to accelerate bringing cancer therapies to clinical trials by providing computational tools and collaborative programs that streamline discovery and optimization.